• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

How much do we pay to get analysts on our side?

anonymous

Guest
Just wondering, is there something more "tangible" than CNBC appearances and cooking the books to make everything lovely (with an occasional dip into retirement funds)?
 

<